Diabetes, Metabolic Syndrome in Mice Treated with Novel Class of Compounds A study in mice — led by researchers at Washington University School of Medicine in St. Louis — shows that a new class of compounds the scientists developed can improve multiple aspects of metabolic syndrome. An increasingly common group
Type 1 Diabetes: Study Uncovers New Avenue Toward Treatment Scientists have already implicated a particular part of a chromosome in type 1 diabetes. However, they did not understand exactly why this region — known as locus 3p21.31 — influences risk. The current study adds more detail. Read more...
Researchers Receive More than $6 Million to Study Diabetes-Related Cardiovascular Disease Over the past two decades, the number of new diabetes cases has almost tripled in the United States, and 80% of patients with Type 2 diabetes die from cardiovascular disease. Read more...
In Lab, SLU Researchers Find Benefits for Diabetes, Fatty Liver Disease When Combining Two Anti-Diabetes Drugs A Saint Louis University research team, led by Kyle S. McCommis, Ph.D., assistant professor in Biochemistry and Molecular Biology, found that combining two classes of anti-diabetes drugs provides superior benefits in mouse models of
Major NIH Study Seeks to Understand Unusual Forms of Diabetes Washington University School of Medicine in St. Louis is part of a national research network aiming to discover rare forms of diabetes as a first step toward providing more effective treatments. Read more...